Medical Research and Clinical Trials

Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

• Medical Research and Clinical Trials

Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

Asep Darmawan May 15, 2026 0

A groundbreaking preclinical study presented at the European Congress on Obesity (ECO) has unveiled the potential of...

Read More Read more about Survodutide Shows Promising Dual Action in Preclinical Models, Offering Hope for Diabetic Kidney Disease and Metabolic Disorders

Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

• Medical Research and Clinical Trials

Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

Azzam Bilal Chamdy May 14, 2026 0

NEW YORK, NY – For decades, the role of regulatory T (Treg) cells in cancer has been...

Read More Read more about Unlocking the Colorectal Cancer Paradox: Landmark Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

• Medical Research and Clinical Trials

UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

Ali Ikhwan May 14, 2026 0

London, UK – [Date of Publication] – The United Kingdom is making a concerted effort to solidify...

Read More Read more about UK’s Ambitious 150-Day Clinical Trial Set-Up Target: A Deep Dive into the NIHR’s Strategic Role

AI-Powered Mammograms Unveil Hidden Cardiovascular Risks, Study Reveals: A Dual-Purpose Screening Revolution on the Horizon

• Medical Research and Clinical Trials

AI-Powered Mammograms Unveil Hidden Cardiovascular Risks, Study Reveals: A Dual-Purpose Screening Revolution on the Horizon

Asep Darmawan May 14, 2026 0

Washington D.C. – A groundbreaking study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25)...

Read More Read more about AI-Powered Mammograms Unveil Hidden Cardiovascular Risks, Study Reveals: A Dual-Purpose Screening Revolution on the Horizon

QuartzBio Secures Major Investment from Eir Partners to Revolutionize Clinical Trial Operations with AI-Powered Intelligence

• Medical Research and Clinical Trials

QuartzBio Secures Major Investment from Eir Partners to Revolutionize Clinical Trial Operations with AI-Powered Intelligence

Raul Delapena Setiawan May 14, 2026 0

[City, State] – [Date] – QuartzBio, a pioneering force in clinical trial intelligence, today announced a significant...

Read More Read more about QuartzBio Secures Major Investment from Eir Partners to Revolutionize Clinical Trial Operations with AI-Powered Intelligence

Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth

• Medical Research and Clinical Trials

Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth

Neng Nana May 14, 2026 0

New York, NY – March 14, 2024 – A pivotal preclinical study spearheaded by investigators at Weill...

Read More Read more about Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth

Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data

• Medical Research and Clinical Trials

Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data

Neng Nana May 14, 2026 0

Boston, MA – [Insert Date] – Alkermes plc today announced encouraging top-line results from its pivotal Phase...

Read More Read more about Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data

A Glimmer of Hope: Pan-Canadian Team Pioneers Rapid Personalized Cancer Treatment for Young Patients Using Egg Avatars and Proteomics

• Medical Research and Clinical Trials

A Glimmer of Hope: Pan-Canadian Team Pioneers Rapid Personalized Cancer Treatment for Young Patients Using Egg Avatars and Proteomics

Asro May 14, 2026 0

VANCOUVER, BC – In a groundbreaking development offering renewed hope to young cancer patients battling aggressive and...

Read More Read more about A Glimmer of Hope: Pan-Canadian Team Pioneers Rapid Personalized Cancer Treatment for Young Patients Using Egg Avatars and Proteomics

Breakthrough in Cystic Fibrosis Treatment: ETD001 Shows Promising Results in Phase II Trial

• Medical Research and Clinical Trials

Breakthrough in Cystic Fibrosis Treatment: ETD001 Shows Promising Results in Phase II Trial

Reynand Wu May 14, 2026 0

Enterprise Therapeutics’ innovative inhaled therapy, ETD001, has demonstrated significant potential in a recent Phase II clinical trial,...

Read More Read more about Breakthrough in Cystic Fibrosis Treatment: ETD001 Shows Promising Results in Phase II Trial

A New Dawn in Ovarian Cancer Treatment: King’s College London Pioneers IgE Antibody Therapy

• Medical Research and Clinical Trials

A New Dawn in Ovarian Cancer Treatment: King’s College London Pioneers IgE Antibody Therapy

Basiran May 13, 2026 0

London, UK – [Insert Current Date] – In a landmark development that promises to reshape the landscape...

Read More Read more about A New Dawn in Ovarian Cancer Treatment: King’s College London Pioneers IgE Antibody Therapy